Keflex (Cephalexin) Treatment Dosage and Duration for UTI
For urinary tract infections (UTIs), cephalexin should be dosed at 500 mg orally four times daily for 7-14 days in adults, with twice daily dosing being an acceptable alternative for uncomplicated UTIs to improve adherence. 1, 2
Adult Dosing Recommendations
Uncomplicated UTIs
- Dosage: 500 mg orally
- Frequency: Four times daily (traditional) or twice daily (alternative)
- Duration: 7-14 days 2, 1
- 7 days is generally sufficient for uncomplicated cases
- 14 days may be needed for more complex cases
Complicated UTIs
- Dosage: 500 mg orally
- Frequency: Four times daily
- Duration: 7-14 days (14 days for men when prostatitis cannot be excluded) 2
Pediatric Dosing Recommendations
Factors Affecting Treatment Decisions
Dosing Frequency Considerations
- Recent evidence suggests twice-daily dosing (500 mg BID) is as effective as four-times-daily dosing for uncomplicated UTIs 3, 4
- Treatment failure rates were not significantly different between twice daily and four times daily regimens (18.7% vs 15.0%, p=0.465) 4
- Twice-daily dosing may improve patient adherence while maintaining efficacy 3
Duration Considerations
- The European Association of Urology and American Academy of Pediatrics both recommend 7-14 days of treatment 2
- Shorter durations (7 days) may be considered when:
- The patient is hemodynamically stable
- The patient has been afebrile for at least 48 hours
- There are relative contraindications to longer antibiotic courses 2
- Longer durations (14 days) are recommended for:
- Males when prostatitis cannot be excluded
- Complicated UTIs with systemic symptoms
- Patients with underlying urological abnormalities 2
Special Populations
Renal Impairment
- Dosage adjustment required for patients with creatinine clearance <30 ml/min 5
- The reduction should be proportional to the reduced renal function
Elderly Patients
- Standard adult dosing can be used unless renal function is impaired
- Twice-daily dosing may improve adherence in elderly patients 6
Clinical Pearls and Pitfalls
- Local resistance patterns: Always consider local susceptibility patterns when selecting cephalexin for UTI treatment 2
- Urine concentrations: Cephalexin achieves high urinary concentrations (500-1000 μg/ml) following standard oral doses, which exceeds the MIC for most urinary pathogens 5
- Avoid for febrile infants: For febrile infants with UTIs, parenteral therapy is often preferred initially 2
- Catheter-associated UTIs: Screening for and treatment of catheter-associated asymptomatic bacteriuria is not recommended 2
- Timing of administration: Cephalexin is absorbed in the upper intestine (not stomach) and achieves rapid distribution to tissues 5
By following these evidence-based recommendations for cephalexin dosing in UTIs, clinicians can optimize treatment outcomes while minimizing adverse effects and promoting antimicrobial stewardship.